Ribociclib (LEE011) Rollover Study for Continued Access

Clinical trial NCT02934568 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02934568
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

Start date: 2016-12-15
Primary completion: 2027-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.